Sign in

CIK 0001101026

  • Non-accelerated filer
  • Smaller reporting company

Zivo Bioscience, Inc.

Sign in to watch
Ticker
ZIVO
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
870699977
Phone
+1 248-452-9866
Business address
21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
Former names
HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
  1. 4 Open-market buy Director bought 18,000 shares at $0.15 ($2,700)
  2. 4 Open-market buy Director bought 102,000 shares at an average $0.13 ($13,350)
  3. 4 Open-market buy Director bought 85,000 shares at $0.12 ($10,200)
  4. 4 Open-market buy Director bought 15,000 shares at $0.11 ($1,650)
  5. 4 Open-market buy Director bought 10,000 shares at an average $0.13 ($1,250)
  6. 4 Open-market buy Director bought 40,000 shares at $0.10 ($4,000)
  7. 4 Open-market buy 10% owner bought 13,088,129 shares at $0.10 ($1,308,813)
  8. 4 Open-market buy Director bought 163,000 shares at an average $0.09 ($15,190)
  9. 4 Open-market buy Director bought 116,000 shares at $0.11 ($12,760)
  10. 4 Open-market buy Director bought 60,000 shares at an average $0.12 ($7,100)
  11. 4 Open-market buy Director bought 116,000 shares at an average $0.09 ($10,650)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4/A Insider Changes in Ownership
  15. 4/A Insider Changes in Ownership
  16. 4/A Insider Changes in Ownership
  17. 3/A Insider 3/A
  18. 4 Open-market buy Director bought 74,000 shares at an average $0.07 ($5,360)
  19. 4 Open-market buy Director bought 103,000 shares at an average $0.09 ($9,490)
  20. 4 Open-market buy Director bought 125,000 shares at an average $0.09 ($11,430)

Page 7 of 12 · 239 filings